• Publications
  • Influence
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
Lack of estrogen receptor (ER) and presence of vimentin (VIM) associate with poor prognosis in human breast cancer. We have explored the relationships between ER, VIM, and invasiveness in humanExpand
  • 528
  • 28
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
Raloxifene, a selective estrogen receptor modulator approved for the prevention and treatment of postmenopausal osteoporosis, has shown a significant reduction in breast cancer incidence after 3Expand
  • 628
  • 23
Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis
SummaryProgression of breast cancer from an estrogen-dependent, slowly growing tumor amenable to tamoxifen treatment to an aggressive, metastatic, estrogen-independent phenotype has been mimicked byExpand
  • 24
  • 1
The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery
Forty-three patients with locally advanced breast cancer, 15 with stage IIIA and 28 with stage IIIB, received primary induction chemotherapy, including hormonal synchronization in 38 patients, to aExpand
  • 18
Phase I trial of pentosan polysulfate
SummaryPentosan polysulfate is a semisynthetic pentasaccharide heparinoid derived from beechwood shavings. A total of nineteen patients with various adult solid tumors were treated with three doseExpand
  • 10
Resistance to endocrine therapy A panel discussion
Endocrine therapy for breast cancer and certain other malignancies remains an important topic for the practicing physician. Thus, an understanding of the circumstances by which patients becomeExpand
  • 3